{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:05:36Z","timestamp":1784127936642,"version":"3.55.0"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,25]]},"DOI":"10.7759\/cureus.45965","type":"journal-article","created":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T06:21:42Z","timestamp":1695709302000},"source":"Crossref","is-referenced-by-count":2,"title":["Acute Exfoliative Dermatitis\/Erythroderma Secondary to Gliclazide"],"prefix":"10.7759","author":[{"given":"Saifaldeen","family":"Al-Badawi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Akber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASW.0000463573.40637.73","article-title":"A review of the diagnosis and management of erythroderma (generalized red skin)","volume":"28","author":"Mistry N","year":"2015","unstructured":"Mistry N, Gupta A, Alavi A, Sibbald RG. A review of the diagnosis and management of erythroderma (generalized red skin). Adv Skin Wound Care. 2015, 28:228-36; quiz 237-8. 10.1097\/01.ASW.0000463573.40637.73","journal-title":"Adv Skin Wound Care"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-75623-3_19","article-title":"Erythroderma","author":"Harper-Kirksey K","year":"2018","unstructured":"Harper-Kirksey K. Erythroderma. Life-Threatening Rashes. 2018, 265-77. 10.1007\/978-3-319-75623-3_19","journal-title":"Life-Threatening Rashes"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.mpmed.2021.04.005","article-title":"Erythroderma and acute skin failure","volume":"49","author":"Patel PU","year":"2021","unstructured":"Patel PU, Levell NJ. Erythroderma and acute skin failure. Emerg Dermatol. 2021, 49:P421-7. 10.1016\/j.mpmed.2021.04.005","journal-title":"Emerg Dermatol"},{"key":"ref4","unstructured":"Erythoderma | DermNet. (2016). Accessed. September 25, 2023: https:\/\/dermnetnz.org\/topics\/erythroderma."},{"key":"ref5","article-title":"Pharmacological and pharmaceutical profile of gliclazide: a review","volume":"1","author":"Sarkar A","year":"2011","unstructured":"Sarkar A, Tiwari A, Bhasin PS, Mitra M. Pharmacological and pharmaceutical profile of gliclazide: a review. J App Pharm Sci. 2011, 1:11-9.","journal-title":"J App Pharm Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.12890\/2019_001119","article-title":"Erythroderma and chronic lichenification due to metformin","volume":"6","author":"D\u00edaz JM","year":"2019","unstructured":"D\u00edaz JM, Bru\u00f1\u00e9n JM, Cameo RB, Gonz\u00e1lez AM. Erythroderma and chronic lichenification due to metformin. Eur J Case Rep Intern Med. 2019, 6:001119. 10.12890\/2019_001119","journal-title":"Eur J Case Rep Intern Med"},{"key":"ref7","unstructured":"Exfoliative Dermatitis. Practice Essentials, Background, Pathophysiology. (2021). Accessed: September 25, 2023: https:\/\/emedicine.medscape.com\/article\/762236-overview#a5."},{"key":"ref8","unstructured":"Naranjo algorithm - Wikipedia. (2023). Accessed. September 25, 2023: https:\/\/en.wikipedia.org\/wiki\/Naranjo_algorithm."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/144447-acute-exfoliative-dermatitiserythroderma-secondary-to-gliclazide","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:06:22Z","timestamp":1707509182000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/144447-acute-exfoliative-dermatitiserythroderma-secondary-to-gliclazide"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,25]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.45965","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,25]]}}}